RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,727,582 | -37.6% | 205,420 | -6.8% | 0.00% | -25.0% |
| Q2 2023 | $2,769,254 | -37.3% | 220,482 | -17.8% | 0.00% | -42.9% |
| Q1 2023 | $4,415,739 | +24.1% | 268,108 | +12.5% | 0.01% | +16.7% |
| Q4 2022 | $3,559,335 | +7.8% | 238,242 | +61.4% | 0.01% | +20.0% |
| Q3 2022 | $3,303,000 | +15.0% | 147,636 | -13.7% | 0.01% | +25.0% |
| Q2 2022 | $2,873,000 | +10.7% | 171,136 | +102.2% | 0.00% | +33.3% |
| Q1 2022 | $2,595,000 | – | 84,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |